We demonstrated that Curcumol would simultaneously reduce VEGF, SDF-1α, and CXCR4 protein levels in the CAG animal model, and the relevant outcomes from in vivo and in vitro experiments of gastric cancer were alike. This evidence concerns the gene CXCR4 and gastric cancer.